Roche Agrees to Acquire PathAI for Up to $1.05 Billion

businessai 2 posts · 2 accounts

Swiss pharmaceutical group Roche has agreed to acquire US-based PathAI, a maker of AI diagnostic tools, in a deal valued at up to $1.05 billion. The transaction includes $750 million upfront and is expected to close in the second half of 2026.

From the sources (2 posts)

@techmeme

Swiss pharmaceutical group Roche agrees to acquire US-based PathAI, which makes AI diagnostic tools, for up to $1.05B, with $750M upfront, closing in H2 2026 (Adrià Calatayud / Wall Street Journal) (Visit Techmeme dot com for the link and

@reuters

Switzerland's Roche agrees to acquire US-based PathAI

MoonPay Acquires Solana Trading Infrastructure Platform DFlow in Reported $100 Million Stock Deal Trump Says He Won't Replace FDA Commissioner Makary After Exit Reports